Omada Health, Inc. (OMDA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $61.00K; Additional Paid in CapitalUSD $707.10M; Retained Earnings (Accumulated Deficit)USD $-454.42M; Stockholders' Equity Attributable to ParentUSD $252.74M.
- 2026-03-31: Common Stock, Value, IssuedUSD $59.00K; Additional Paid in CapitalUSD $693.77M; Retained Earnings (Accumulated Deficit)USD $-459.71M; Stockholders' Equity Attributable to ParentUSD $234.12M.
- 2025-12-31: Common Stock, Value, IssuedUSD $58.00K; Additional Paid in CapitalUSD $686.37M; Retained Earnings (Accumulated Deficit)USD $-456.74M; Stockholders' Equity Attributable to ParentUSD $229.68M.
- 2025-09-30: Common Stock, Value, IssuedUSD $58.00K; Additional Paid in CapitalUSD $679.19M; Retained Earnings (Accumulated Deficit)USD $-461.90M; Stockholders' Equity Attributable to ParentUSD $217.35M.
Omada Health, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|
| 2026-06-30 | $61.00K | $707.10M | $-454.42M | $252.74M | 3 month · $5.72M |
| 2026-03-31 | $59.00K | $693.77M | $-459.71M | $234.12M | 3 month · $4.29M |
| 2025-12-31 | $58.00K | $686.37M | $-456.74M | $229.68M | 12 month · $13.14M |
| 2025-09-30 | $58.00K | $679.19M | $-461.90M | $217.35M | 3 month · $3.58M |
| 2025-06-30 | $56.00K | $672.88M | $-458.73M | $214.21M | 3 month · $2.87M |
| 2025-03-31 | (m) | (m) | (m) | $-390.05M | 3 month · $2.88M |
| 2024-12-31 | $8.00K | $59.55M | $-443.97M | $-384.40M | 12 month · $9.52M |
| 2024-09-30 | (m) | (m) | (m) | $-379.77M | 3 month · $2.19M |
| 2024-06-30 | (m) | (m) | (m) | $-373.40M | 3 month · $2.11M |
| 2024-03-31 | (m) | (m) | (m) | $-365.21M | 3 month · $2.89M |
| 2023-12-31 | (m) | (m) | (m) | $-350.11M | 12 month · $8.82M |
| 2022-12-31 | (m) | (m) | (m) | $-293.17M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |